These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 35451976)

  • 21. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing the Efficacy of a Social Networking Gamification App to Improve Pre-Exposure Prophylaxis Adherence (P3: Prepared, Protected, emPowered): Protocol for a Randomized Controlled Trial.
    LeGrand S; Knudtson K; Benkeser D; Muessig K; Mcgee A; Sullivan PS; Hightow-Weidman L
    JMIR Res Protoc; 2018 Dec; 7(12):e10448. PubMed ID: 30563818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Providing HIV pre-exposure prophylaxis to men who have sex with men and transgender women in hospitals and community-led clinics in Thailand: acceptance, patterns of use, trends in risk behaviors, and HIV incidence.
    L C; M C; P N; T D; K T; P T; P S; P P; V P; J S; L D; N T; J N; M M
    AIDS Care; 2023 Apr; 35(4):524-537. PubMed ID: 36726288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
    Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DP.
    Jongen VW; Hoornenborg E; van den Elshout MA; Boyd A; Zimmermann HM; Coyer L; Davidovich U; Anderson PL; de Vries HJ; Prins M; Schim van der Loeff MF;
    J Int AIDS Soc; 2021 May; 24(5):e25708. PubMed ID: 33973373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake and Acceptability of MyChoices: Results of a Pilot RCT of a Mobile App Designed to Increase HIV Testing and PrEP Uptake Among Young American MSM.
    Biello KB; Daddario SR; Hill-Rorie J; Futterman D; Sullivan PS; Hightow-Weidman L; Jones J; Mimiaga MJ; Mayer KH
    AIDS Behav; 2022 Dec; 26(12):3981-3990. PubMed ID: 35829971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial.
    Celum CL; Gill K; Morton JF; Stein G; Myers L; Thomas KK; McConnell M; van der Straten A; Baeten JM; Duyver M; Mendel E; Naidoo K; Dallimore J; Wiesner L; Bekker LG
    J Int AIDS Soc; 2020 Nov; 23(11):e25636. PubMed ID: 33247553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
    Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D;
    Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of HIV Self-Testing on PrEP Adherence Among Gender-Diverse Sex Workers in Uganda: A Randomized Trial.
    Mujugira A; Nakyanzi A; Nabaggala MS; Muwonge TR; Ssebuliba T; Bagaya M; Nampewo O; Sapiri O; Nyanzi KR; Bambia F; Nsubuga R; Serwadda DM; Ware NC; Baeten JM; Haberer JE
    J Acquir Immune Defic Syndr; 2022 Apr; 89(4):381-389. PubMed ID: 34954718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.
    Velloza J; Donnell D; Hosek S; Anderson PL; Chirenje ZM; Mgodi N; Bekker LG; Marzinke MA; Delany-Moretlwe S; Celum C
    Lancet HIV; 2022 Oct; 9(10):e680-e689. PubMed ID: 36087612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial.
    Swendeman D; Rotheram-Borus MJ; Arnold EM; Fernández MI; Comulada WS; Lee SJ; Ocasio MA; Ishimoto K; Gertsch W; Duan N; Reback CJ; Murphy DA; Lewis KA;
    Lancet Digit Health; 2024 Mar; 6(3):e187-e200. PubMed ID: 38395539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.
    Kimani M; van der Elst EM; Chirro O; Wahome E; Ibrahim F; Mukuria N; de Wit TFR; Graham SM; Operario D; Sanders EJ
    PLoS One; 2021; 16(1):e0244226. PubMed ID: 33465090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Multicomponent Intervention (POSSIBLE) to Improve Perceived Risk for HIV Among Black Sexual Minority Men: Feasibility and Preliminary Effectiveness Pilot Study.
    Dangerfield Ii DT; Anderson JN; Wylie C; Bluthenthal R; Beyrer C; Farley JE
    JMIR Hum Factors; 2024 Jun; 11():e54739. PubMed ID: 38861707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention in an mHealth App Aiming to Promote the Use of HIV Pre-Exposure Prophylaxis Among Female Sex Workers in Dar es Salaam, Tanzania: Prospective Cohort Study.
    Mbotwa CH; Kazaura MR; Moen K; Leshabari MT; Metta E; Mmbaga EJ
    JMIR Mhealth Uhealth; 2023 Oct; 11():e46853. PubMed ID: 37855221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Condomless Anal Sex Associated With Heterogeneous Profiles Of HIV Pre-Exposure Prophylaxis Use and Sexual Activities Among Men Who Have Sex With Men: A Latent Class Analysis Using Sex Diary Data on a Mobile App.
    Yu YF; Wu HJ; Ku SW; Huang PH; Li CW; Huang P; Strong C
    J Med Internet Res; 2021 Dec; 23(12):e33877. PubMed ID: 34941560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a Reminder System on Pre-exposure Prophylaxis Adherence in Men Who Have Sex With Men: Prospective Cohort Study Based on WeChat Intervention.
    Lin B; Liu J; He W; Pan H; Ma Y; Zhong X
    J Med Internet Res; 2022 Aug; 24(8):e37936. PubMed ID: 35969436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mobile App (UPrEPU) to Monitor Adherence to Pre-exposure Prophylaxis in Men Who Have Sex With Men: Protocol for a User-Centered Approach to Mobile App Design and Development.
    Strong C; Wu HJ; Tseng YC; Yuan CW; Yu YF; Liao JC; Chen YW; Hung YC; Li CW; Huang PH; Ko NY; Ku SW
    JMIR Res Protoc; 2020 Dec; 9(12):e20360. PubMed ID: 33258793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral Efficacy of a Sexual Health Mobile App for Men Who Have Sex With Men: Randomized Controlled Trial of Mobile Messaging for Men.
    Sullivan PS; Stephenson R; Hirshfield S; Mehta CC; Zahn R; Bauermeister JA; Horvath K; Chiasson MA; Gelaude D; Mullin S; Downing MJ; Olansky EJ; Wiatrek S; Rogers EQ; Rosenberg E; Siegler AJ; Mansergh G
    J Med Internet Res; 2022 Feb; 24(2):e34574. PubMed ID: 35025755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Mobile-Based App (MyChoices) to Increase Uptake of HIV Testing and Pre-Exposure Prophylaxis by Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial.
    Biello KB; Marrow E; Mimiaga MJ; Sullivan P; Hightow-Weidman L; Mayer KH
    JMIR Res Protoc; 2019 Jan; 8(1):e10694. PubMed ID: 30617042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.